EF5
From Infogalactic: the planetary knowledge core
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
200px | |
Names | |
---|---|
IUPAC name
2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide
|
|
Other names
NSC-684681; EF-5
|
|
Identifiers | |
152721-37-4 ![]() |
|
ChemSpider | 344807 ![]() |
Jmol 3D model | Interactive image |
PubChem | 389053 |
UNII | 383HJ2T87O ![]() |
|
|
|
|
Properties | |
C8H7F5N4O3 | |
Molar mass | 302.16 g·mol−1 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
EF5 is a nitroimidazole used in oncology research.[1] Due to its similarity in chemical structure to etanidazole, EF5 binds in cells displaying hypoxia.[2]
The 18F-radiolabeled derivative of EF5 is being studied for its possibility to be used in positron emission tomography (PET) to detect low levels of oxygen in brain tumors.[3] This can help show how a tumor will respond to treatment.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />